• Publications
  • Influence
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in
Members of the Chamber Quantification Writing Group are: Roberto M. Lang, MD, FASE, Michelle Bierig, MPH, RDCS, FASE, Richard B. Devereux, MD, Frank A. Flachskampf, MD, Elyse Foster, MD, Patricia A.Expand
  • 9,888
  • 623
  • PDF
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
on Statement: Society of Echocardiography is accredited by the Accreditation Council for edical Education to provide continuing medical education for physicians. n Society of EchocardiographyExpand
  • 4,268
  • 419
  • PDF
Recommendations for chamber quantification.
Quantification of cardiac chamber size, ventricular mass and function ranks among the most clinically important and most frequently requested tasks of echocardiography. Over the last decades,Expand
  • 3,876
  • 299
  • PDF
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
BACKGROUND We compared the angiotensin receptor-neprilysin inhibitor LCZ696 with enalapril in patients who had heart failure with a reduced ejection fraction. In previous studies, enalapril improvedExpand
  • 3,036
  • 187
  • PDF
Cardiac-resynchronization therapy for the prevention of heart-failure events.
BACKGROUND This trial was designed to determine whether cardiac-resynchronization therapy (CRT) with biventricular pacing would reduce the risk of death or heart-failure events in patients with mildExpand
  • 2,323
  • 81
  • PDF
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hy...
  • 1,040
  • 75
  • PDF
Strategies for multivessel revascularization in patients with diabetes.
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronaryExpand
  • 1,336
  • 70
  • PDF
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
BACKGROUND Cardiovascular morbidity and mortality are higher among patients with type 2 diabetes, particularly those with concomitant cardiovascular diseases, than in most other populations. WeExpand
  • 1,306
  • 66
  • PDF
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
BACKGROUND Angiotensin-converting-enzyme (ACE) inhibitors such as captopril reduce mortality and cardiovascular morbidity among patients with myocardial infarction complicated by left ventricularExpand
  • 2,223
  • 64
  • PDF
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
BACKGROUND The presence of coexisting conditions has a substantial effect on the outcome of acute myocardial infarction. Renal failure is associated with one of the highest risks, but the influenceExpand
  • 1,766
  • 60